Microfluidic platforms for the validation of new targeted therapies for personalised medicine against osteosarcoma.
Cancer is a leading cause of mortality in the world, with osteosarcoma being one of the most common types among children between 1 and 14 years old. Current treatments including preoperative chemotherapy, surgery and postoperative chemotherapy produce several side effects with limited effectiveness....
| Main Authors: | , , |
|---|---|
| Format: | info:eu-repo/semantics/doctoralThesis |
| Language: | eng |
| Published: |
Servicio de Publicaciones. Universidad de Navarra
2021
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10171/62150 |